Bashar Qumseya, MD, MPH
Basic profileBashar Qumseya is a Gastroenterology physician affiliated with University of Florida Health. OpenAlex indexes 255 publications with 7,446 citations (h-index 43); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Fujifilm Healthcare Americas CorporationProgram year20252 payments$317
- Boston Scientific CorporationProgram year20252 payments$60
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment$51
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
60.5%Proton pump inhibitor47.4%Pantoprazole Sodium39%Omeprazole29%Rabeprazole Sodium25%Esomeprazole Magnesium6%Part D<11 patientsOsmotic Laxative8.1%Lactulose53%Gavilyte-G47%Part D<11 patients+ 1 more class in this area
Blood & clotting
31.2%Solutions for parenteral nutrition31.2%Peg 3350-Electrolyte100%Part D≥123 patientsAnti-infectives
4.3%Macrolide Antimicrobial4.3%Azithromycin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Jamie Conti, MD
University of Florida Health
Westley Reeves, MD
University of Florida Health
Borna Mehrad, MD
University of Florida Health
Joanne Lagmay, MD
University of Florida Health
Charles Rice, MD
The Rockefeller University
Jean-Frederic Colombel, MD
Icahn School of Medicine at Mount Sinai
Edward Loftus, MD
Mayo Clinic Rochester
Kris Kowdley, MD
Washington State University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”